TET2

There are 294 papers on TET2 in aging research: 3 trials and 141 observational studies in people, 61 in animals, 15 in cells, 64 reviews. The newest story, Nov 10, 2026: “Drug may target lab-grown human cells with reduced TET2 gene function”.

Gene

294 papers study it122 findings

HGNCMGINCBI GeneTaxon

31 new papers in 30 daysSee all 294 papers on TET2

At a glance

TET2 is associated with mortality and type 2 diabetes in human studies, with independent labs reporting these links again. Mouse studies from one group report opposing effects on senescence; a mouse study finds that hippocampal TET2 overexpression protects against age-related neurogenesis decline. Some papers declare company ties, and some authors have company affiliations.

122 findings in 93 papers from 2016 to 2026, 28 of them since April 2026

Independent labs found the same change in people. 56 independent labs in 16 countries.

“GCA risk was highest among individuals with cytopenia (hazard ratio [HR] 2.98, P = 0.00178) and with TET2 mutation (HR 2.02, P = 0.00116).”
Association of Somatic TET2 Mutations With Giant Cell ArteritisArthritis & rheumatology (Hoboken, N.J.)2023doi:10.1002/art.42738

4 of its findings point the other way.

Humans: replicated by independent labs. Cells and mice: a single group. Worms or flies: nothing yet.
  • 56 independent labs in 16 countries
  • 4 findings against
  • Funders: National Heart, Lung, and Blood Institute and others
  • 17 of 102 findings with company ties
  • Human trial3
  • Humans141
  • Animals61
  • Cells15
  • In silico5

Interventions

5

Oxytocin

upin mice1

1 study
  1. Oxytocin increases TET2 in mice.

    “Nasal application of OXT (10 μg/day) for 10 days to aged mice resulted in normalized plasma OXT and inflammation levels and a recovery of OXT-positive neurons, TET2 mRNA levels”

    Animalsnasal applicationhypothalamus10 μg/day10 days

    Oxytocin Enhances Demethylation Through TET Enzyme Expression in Neurons of Aged Mice: Oxytocin as a Potential Antiaging Peptide

    Aging cell

More on Oxytocin

GDF11

upin cells1

1 study
  1. GDF11 increases TET2 in cells.

    “GDF11 also upregulated a DNA demethylase Tet2”

    Cells

    Mutual regulation between GDF11 and TET2 prevents senescence of mesenchymal stem cells

    Journal of cellular physiology

More on GDF11

Hydrogen sulfide

downin mouse cells1

1 study
  1. Hydrogen sulfide inhibits TET2 in vitro.

    “The exogenous addition of H2S inhibited Ten eleven translocation 2 (TET2) activity in vitro, thus providing a potential mechanism of action.”

    Cellsin vitro

    Sulfur Amino Acid Supplementation Abrogates Protective Effects of Caloric Restriction for Enhancing Bone Marrow Regrowth Following Ionizing Radiation

    Nutrients

More on Hydrogen sulfide

Molecular hydrogen

upin humans1

1 study
  1. Molecular hydrogen increases TET2 in humans (older adults) (from 0.81 ± 0.52 to 1.62 ± 0.66 vs control 1.13 ± 0.82 to 1.76 ± 0.87).

    “the degree of elevation was significantly higher in HRW (from 0.81 ± 0.52 at baseline to 1.62 ± 0.66 at follow up) comparing to the control water (from 1.13 ± 0.82 to 1.76 ± 0.87) (P = 0.040).”

    Human trialolder adultsblood0.5 L per day (15 ppm)6-monthn = 40

    The effects of 6-month hydrogen-rich water intake on molecular and phenotypic biomarkers of aging in older adults aged 70 years and over: A randomized controlled pilot trial

    Experimental gerontology

More on Molecular hydrogen

Heterochronic parabiosis

upin mice1

1 study
  1. Heterochronic parabiosis increases TET2 in mice (heterochronic parabiosis rejuvenation model).

    “In a heterochronic parabiosis rejuvenation model, hippocampal Tet2 expression was restored.”

    Animalsheterochronic parabiosis rejuvenation modelhippocampus

    Tet2 Rescues Age-Related Regenerative Decline and Enhances Cognitive Function in the Adult Mouse Brain

    Cell reports

More on Heterochronic parabiosis

Effects

58

Inflammation

downin animals1downin humans1upin mice1

3 studies
  1. TET2 is linked with lower inflammation in humans (relative to wild-type HSCs within the same sample).

    “DNMT3A and TET2 -mutant HSCs have an attenuated inflammatory response relative to wild-type HSCs within the same sample”

    Humansrelative to wild-type HSCs within the same samplebone marrow

    Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  2. TET2 decreases inflammation (shown by Tet2 knockout).

    “These findings reveal that Tet2 suppresses inflammation by gating nutrient-responsive chromatin remodeling”

    Animalsshown by Tet2 knockout

    Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis

    Cell chemical biology

  3. TET2 increases inflammation in mice (TLR9 agonism with ODN1826; shown by mutation).

    “macrophages carrying mutations in Tet2, one of the most commonly mutated genes in CH, have an enhanced inflammatory response to TLR9 agonism”

    AnimalsTLR9 agonism with ODN1826; shown by mutationmacrophage

    Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis

    Blood

More on Inflammation

Cellular senescence

downin mice1upin mice1

2 studies
  1. TET2 inhibits cellular senescence in mice (shown by endothelial Tet2 knockout).

    “Tet2 ECiKO mice also developed prominent endothelial senescence, indicating accelerated vascular aging.”

    Animalsshown by endothelial Tet2 knockoutvascular endothelium

    Loss of a DNA regulator speeds lung vessel aging in mice

    AHA Scientific Sessions 2026 abstract

  2. TET2 induces cellular senescence in mice.

    “This study confirmed that TET2-mediated PTEN DNA methylation can promote a new mechanism of β cell senescence by regulating H4K16ac”

    Animals

    TET2-mediated epigenetic modification promotes stress senescence of pancreatic β cells in type 2 diabetes mellitus

    eLifePreprint

More on Cellular senescence

Myeloid maturation

upin humans2

2 studies
  1. TET2 is linked with higher myeloid maturation in humans.

    “TET2 mutations accelerate myeloid maturation in a dose-dependent manner.”

    Humansbone marrow

    Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging

    Cell stem cell

  2. TET2 is linked with higher myeloid maturation in humans (dose-dependent manner in CH bone marrow samples).

    “TET2 mutations accelerate myeloid maturation in a dose-dependent manner”

    Humansdose-dependent manner in CH bone marrow samplesbone marrow

    Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

Learning and memory

is required forin mice1upin mice1

1 study
  1. TET2 is required for learning and memory in mice (shown by abrogation of Tet2 in young adults, which impaired learning and memory).

    “abrogating Tet2 expression within the hippocampal neurogenic niche, or adult neural stem cells, decreased neurogenesis and impaired learning and memory”

    Animalsshown by abrogation of Tet2 in young adults, which impaired learning and memoryhippocampus

    Tet2 Rescues Age-Related Regenerative Decline and Enhances Cognitive Function in the Adult Mouse Brain

    Cell reports

  2. TET2 improves learning and memory in mice (overexpression in the hippocampal neurogenic niche of mature adults).

    “and enhanced learning and memory”

    Animalsoverexpression in the hippocampal neurogenic niche of mature adultshippocampus

    Tet2 Rescues Age-Related Regenerative Decline and Enhances Cognitive Function in the Adult Mouse Brain

    Cell reports

Foam cell formation

downin mouse cells1

1 study
  1. TET2 decreases foam cell formation in mouse cells (shown by Tet2 knockout with oxidized LDL stimulation) (WT versus Tet2 knockout: DiI-oxLDL uptake MFI 39,660 versus 52,488; Oil Red O-positive vesicles 10 versus 18).

    “higher number of oil red o+ vesicles (10 vs 18, p<0.05), indicating enhanced foam cell formation.”

    Cellsshown by Tet2 knockout with oxidized LDL stimulationbone marrow-derived macrophage

    TET2-Mutant Clonal Hematopoiesis Accelerates Atherosclerosis by Cell-Autonomous and Bystander Foam Cell Formation

    AHA Scientific Sessions 2026 abstract

Lung fibrosis

downin mice1

1 study
  1. TET2 decreases lung fibrosis in mice (shown by endothelial Tet2 knockout).

    “Tet2 ECiKO mice further exhibited lung fibrosis, indicating broader vascular and parenchymal remodeling.”

    Animalsshown by endothelial Tet2 knockoutlung

    Loss of a DNA regulator speeds lung vessel aging in mice

    AHA Scientific Sessions 2026 abstract

More on Lung fibrosis

Pulmonary vascular remodeling

downin mice1

1 study
  1. TET2 decreases pulmonary vascular remodeling in mice (shown by endothelial Tet2 knockout).

    “Tet2 ECiKO lungs showed distal pulmonary vascular remodeling, including muscularization of small vessels and abnormal microvascular remodeling.”

    Animalsshown by endothelial Tet2 knockoutlung

    Loss of a DNA regulator speeds lung vessel aging in mice

    AHA Scientific Sessions 2026 abstract

Pulmonary hypertension

downin mice1

1 study
  1. TET2 protects against pulmonary hypertension in mice (shown by inducible endothelial cell-specific Tet2 knockout versus littermate controls) (RVSP exceeding 40 mmHg after endothelial Tet2 deletion).

    “Endothelial Tet2 deletion caused spontaneous PH by 8 months, with RVSP exceeding 40 mmHg in Tet2 ECiKO mice compared with controls.”

    Animalsshown by inducible endothelial cell-specific Tet2 knockout versus littermate controlspulmonary vasculature

    Loss of a DNA regulator speeds lung vessel aging in mice

    AHA Scientific Sessions 2026 abstract

More on Pulmonary hypertension

Cardiomyopathy

downin mice1

1 study
  1. TET2 protects against cardiomyopathy in mice (Shown by 10% Tet2 knockout CHIP).

    “In mice, 10% Tet2 KO -CHIP and 10% Dnmt3a R878H -CHIP exhibited systolic LV dysfunction and cardiomyopathy.”

    AnimalsShown by 10% Tet2 knockout CHIPheart

    The Impact of Clonal Hematopoiesis Variants on Cardiovascular Outcomes and Metabolic Profiles

    AHA Scientific Sessions 2026 abstract

More on Cardiomyopathy

Physical function

downin mice1

1 study
  1. TET2 impairs physical function in mice (Tet2 model).

    “Tet2 mouse model demonstrated multisystem frailty-like functional decline and T-cell remodeling”

    AnimalsTet2 model

    Clonal hematopoiesis is linked to frailty in human cohorts

    medRxivPreprint

All 58

Associations

49

Heart failure with preserved ejection fraction

upin humans2HR 2.5

2 studies
  1. TET2 is linked with a higher risk of heart failure with preserved ejection fraction in humans (aHR 1.40 (95% CI: 1.03-1.90)).

    “TET2 CHIP was associated with HFpEF (aHR: 1.40 [95% CI: 1.03-1.90]; P = 0.03)”

    Humansmedian follow-up 10.1 yearsfemalesn = 6,677

    Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women

    Journal of the American College of Cardiology

  2. TET2 is associated with heart failure with preserved ejection fraction in humans (TET2 mutation carriers) (HR 2.50, 95% CI 1.54–4.06).

    “TET2 strongly drives incident HF with preserved ejection fraction (HR=2.50, 95%CI 1.54-4.06)”

    ReviewTET2 mutation carriers

    Clonal Hematopoiesis of Indeterminate Potential as a Cardiovascular Driver - An Umbrella Review of Systematic Reviews and Meta-Analyses

    AHA Scientific Sessions 2026 abstract

More on Heart failure with preserved ejection fraction

Mortality

upin humans2HR 3.72

2 studies
  1. TET2 is associated with mortality in humans (donor TET2 Leu1721Trp variant in allogeneic HSCT recipients) (median 14.3 months compared with 50.8 months for wild type).

    “A key finding was the significant association between the presence of the donor TET2 Leu1721Trp variant and reduced overall survival in recipients (median 14.3 months compared with 50.8 months for wild type; p = 0.0100).”

    Humansdonor TET2 Leu1721Trp variant in allogeneic HSCT recipientsn = 20

    Donor TET2 variant linked to lower stem cell transplant survival

    International journal of molecular sciences

  2. TET2 is associated with mortality in humans (Adjusted HR 3.72, 95% CI 1.37–10.09; p = 0.010).

    “with analysis of specific mutations identifying particularly high risks for TET2 (adjusted HR: 3.72, 95% CI: 1.37-10.09; p = 0.010)”

    HumansTET2 mutations in acute myocardial infarction patients with hemoglobin glycation index above the median

    The Predictive Value of Hemoglobin Glycation Index and Clonal Hematopoiesis of Indeterminate Potential Among AMI Patients-A Prospective Registry Study

    Journal of diabetes

Venous thromboembolism

upin humans2HR 1.33–2.25

2 studies
  1. TET2 is linked with a higher risk of venous thromboembolism in humans (HR 2.25, 95% CI 1.27-4.00).

    “TET2 mutation was significantly associated with VTE risk (hazard ratio, 2.25; 95% CI, 1.27-4.00; P = .006).”

    Humansmedian 7.1-year follow-upn = 3,980

    Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adults

    Journal of thrombosis and haemostasis : JTH

  2. TET2 is associated with venous thromboembolism in humans (HR 1.33 (95% CI, 1.05-1.69)).

    “TET2-mutant CHIP was associated with incident VTE with a HR of 1.33 (95% CI, 1.05-1.69; P = .02)”

    Humansn = 400,000

    JAK2-mutant clonal hematopoiesis is associated with venous thromboembolism

    Blood

More on Venous thromboembolism

Type 2 diabetes

upin humans2HR 1.48

2 studies
  1. TET2 is linked with a higher risk of type 2 diabetes in humans (CHIP mutation in TET2) (HR 1.48 (CI 1.05–2.08)).

    “higher risk was for TET2 (HR 1.48; CI 1.05, 2.08) and ASXL1 (HR 1.76; CI 1.03, 2.99) mutations”

    HumansCHIP mutation in TET2

    Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk

    Diabetes care

  2. TET2 is associated with type 2 diabetes in stable coronary artery disease (p < 0.001).

    “Mutated TET2 correlated with type 2 diabetes (p < 0.001)”

    Humansin stable coronary artery diseasen = 1,001

    TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients-A Possible Link to Clonal Hematopoiesis

    Biomedicines

More on Type 2 diabetes

Succinate

upin humans1

1 study
  1. TET2 is associated with succinate in humans (Cancer patients with TET2-CHIP).

    “Plasma succinate and glutamine levels were increased in patients and mice with TET2- CHIP”

    HumansCancer patients with TET2-CHIPplasma

    The Impact of Clonal Hematopoiesis Variants on Cardiovascular Outcomes and Metabolic Profiles

    AHA Scientific Sessions 2026 abstract

More on Succinate

Incident obstructive coronary artery disease

upin humans1HR 1.84

1 study
  1. TET2 is associated with incident obstructive coronary artery disease in humans (TET2 mutations among CHIP subtypes) (HR 1.84, 95% CI 1.52–2.23).

    “TET2 mutations confer the highest risk (1.84; 95% CI 1.52-2.23; p<0.001) among CHIP subtypes.”

    HumansTET2 mutations among CHIP subtypes10 years

    Blood-cell mutations linked to later coronary disease

    AHA Scientific Sessions 2026 abstract

More on Incident obstructive coronary artery disease

Shared somatic mutation in lymphoma and bone marrow

mixedin humans1

1 study
  1. TET2 is associated with shared somatic mutation in lymphoma and bone marrow in humans (nodal T follicular helper cell lymphoma).

    “Shared TET2 mutation was identified in both lymphoma and bone marrow”

    Humansnodal T follicular helper cell lymphomalymphoma and bone marrowfemales

    Nodal T Follicular Helper Cell Lymphoma With Epstein-Barr Virus-Positive Neoplastic T Cells Derived From Clonal Hematopoiesis

    EJHaem

More on Shared somatic mutation in lymphoma and bone marrow

Large B-cell lymphoma

upin humans1

1 study
  1. TET2 is associated with large B-cell lymphoma in humans (High-risk primary large B-cell lymphoma compared with healthy controls).

    “Compared with healthy controls, TET2 mutations were enriched in peripheral blood (PB) samples of LBCL patients (P=0.01).”

    HumansHigh-risk primary large B-cell lymphoma compared with healthy controlsperipheral bloodn = 247

    Clonal hematopoiesis and cell-free DNA characteristics in patients with high-risk large B-cell lymphomas

    medRxivPreprint

More on Large B-cell lymphoma

Diastolic dysfunction

upin humans1

1 study
  1. TET2 is associated with diastolic dysfunction in humans.

    “TET2 mutations, in particular, have been consistently linked to diastolic dysfunction and adverse remodeling, especially in patients with high inflammatory burden and cardiometabolic comorbidities.”

    ReviewTET2 mutations, especially in patients with high inflammatory burden and cardiometabolic comorbiditiesheart

    Clonal Hematopoiesis and Inflammatory Pathways in Heart Failure with Preserved Ejection Fraction

    Current heart failure reports

More on Diastolic dysfunction

Response to immune checkpoint inhibitors

upin humans1

1 study
  1. TET2 is associated with response to immune checkpoint inhibitors in humans (TET2-mutant clonal hematopoiesis in clinical immune checkpoint inhibitor cohorts).

    “Clinical ICI cohorts report favorable TET2-associated efficacy signals”

    ReviewTET2-mutant clonal hematopoiesis in clinical immune checkpoint inhibitor cohorts

    Clonal hematopoiesis of indeterminate potential and cancer immunotherapy: a host-intrinsic immune-inflammatory modifier of treatment efficacy and toxicity

    Frontiers in oncology

All 49

Funding

21 grants since 2017

National Heart, Lung, and Blood Institute$10.2MNational Cancer Institute$3.7MGouvernement du Canada | Canadian Institutes of Health ResearchCA$1.2M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Somatic TET2 mutations are linked with shorter lifespan in a human cohort; independent labs link TET2 with type 2 diabetes. Hippocampal TET2 overexpression improves neurogenesis and memory in mature adult mice, although neurogenesis and human telomere-length results differ across studies. Eight of 49 papers declare company ties, and one finding has a Biogen-affiliated author.

  2. Summary rewritten as its findings changed.

    As it read before

    Human cohorts link TET2 mutations to increased mortality following allogeneic hematopoietic stem cell transplantation and graft occlusion in peripheral arterial disease. In mice, TET2 impairs physical function.

  3. Summary written from the findings.

Latest

Dec 2025: 3Jan 2026: 11Feb 2026: 16Mar 2026: 8Apr 2026: 8May 2026: 7Jun 2026: 4Jul 2026: 8Aug 2026: 17Sep 2026: 15Oct 2026: 27Nov 2026: 11135 papers in 12 months
bioRxiv

Blood-cell mutations had opposite effects on breast tumors in mice

As mice aged, mutations in the Dnmt3a gene prevented breast cancer progression, while mutations in the Tet2 gene drove it.As mice aged, mutations in the Dnmt3a gene prevented breast cancer progression, while mutations in the Tet2 gene drove it.

Preprint: mouse studyMechanisms
bioRxiv

Mutation patterns linked to blood cancer in inherited disorders

An analysis of 658 samples from 309 patients with inherited blood disorders linked distinct mutation sequences to progression toward blood cancers.An analysis of 658 samples from 309 patients with inherited blood disorders linked distinct mutation sequences to progression toward blood cancers.

Preprint: cohort · 309 peopleMechanisms
Advanced Science

Drug may target lab-grown human cells with reduced TET2 gene function

A 48-hour screen of 489 compounds identified lanatoside C as a candidate for preferentially killing human immune cells with reduced TET2 gene function.A 48-hour screen of 489 compounds identified lanatoside C as a candidate for preferentially killing human immune cells with reduced TET2 gene function.

Human cell studyInterventions
AHA Scientific Sessions 2026 Abstract

Loss of a DNA regulator speeds lung vessel aging in mice

Mice lacking the regulator developed high lung blood pressure by 8 months; right-heart pumping pressure exceeded 40 millimeters of mercury, compared with control mice.Mice lacking the regulator developed high lung blood pressure by 8 months; right-heart pumping pressure exceeded 40 millimeters of mercury, compared with control mice.

AHA Scientific Sessions 2026 Abstract

Blood-cell mutations linked to later coronary disease

Over 10 years, the hazard ratio—a comparison of disease rates over time—was 1.61 for participants with the condition versus those without it.Over 10 years, the hazard ratio—a comparison of disease rates over time—was 1.61 for participants with the condition versus those without it.

Cohort · 28,312 peopleBiomarkers

See all 294 papers on TET2